Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | UTS2R | Q9UKP6 | 3/20 | 0.38 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.37 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6926420 | 1.00 | ALDH1A1 (0.44) | ALDH1A1HPGDCYP2D6ANPEPDPP4 | |
| SCHEMBL6919908 | 1.00 | ALDH1A1 (0.44) | ALDH1A1HPGDCYP2D6ANPEPDPP4 | |
| SCHEMBL607042 | 0.77 | LMNA (0.58) | ALDH1A1HPGDCYP2D6CSNK2BCSNK2A1 | |
| SCHEMBL29393294 | 0.77 | LMNA (0.58) | ALDH1A1HPGDCYP2D6CSNK2BCSNK2A1 | |
| SCHEMBL6925572 | 0.77 | LMNA (0.58) | ALDH1A1HPGDCYP2D6CSNK2BCSNK2A1 | |
| SCHEMBL6101023 | 0.76 | ALDH1A1 (0.42) | ALDH1A1HPGDCYP2D6FAAHMAPT | |
| SCHEMBL7557936 | 0.76 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP2D6FAAHMAPT | |
| SCHEMBL6921473 | 0.74 | ANPEP (0.45) | ALDH1A1ANPEPDPP4 | |
| SCHEMBL6924635 | 0.74 | ANPEP (0.45) | ALDH1A1ANPEPDPP4 | |
| SCHEMBL6924631 | 0.74 | ANPEP (0.45) | ALDH1A1ANPEPDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119558757-A | Express delivery path planning method based on shortest loop | 东莞职业技术学院 | 2025-03-04 | — | — | CN | claimed |
| EP-4169458-B1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | CILAG GMBH INT (CH) | 2025-01-29 | — | — | EP | claimed |
| CN-117689091-A | TSP shortest path planning method, equipment and storage medium based on straight line field | 东莞职业技术学院 | 2024-03-12 | — | — | CN | claimed |
| EP-4007536-B1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | CILAG GMBH INT (CH) | 2022-12-28 | — | — | EP | claimed |
| US-12639042-B2 | Integrated circuits for large-scale transistor tensor operations | Teracore Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12611211-B2 | Method of operating a surgical instrument | CILAG GMBH INTERNATIONAL (CH) | 2026-04-28 | — | — | US | disclosed |
| US-20260073966-A1 | INTEGRATED CIRCUITS FOR LARGE-SCALE TRANSISTOR TENSOR OPERATIONS | TERACORE SYSTEM INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260072645-A1 | INTEGRATED CIRCUITS FOR LARGE-SCALE TRANSISTOR TENSOR OPERATIONS | Teracore Systems, Inc. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250333460-A1 | MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES AND USES THEREOF | 89BIO LTD. (IL) | 2025-10-30 | — | — | US | disclosed |
| CN-120148175-A | Method, equipment and medium for intelligently analyzing fire occurrence trend and generating report | 武汉江汉城市科技发展有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120058627-A | Mitochondria targeting probe and preparation method and application thereof | 中国科学院上海药物研究所 | 2025-05-30 | — | — | CN | disclosed |
| US-20250160825-A1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | CILAG GMBH INT (CH) | 2025-05-22 | — | — | US | disclosed |
| EP-4007536-A1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | Cilag GmbH International (CH) | 2022-06-08 | — | — | EP | disclosed |
| CN-107229543-B | Semiconductor device with a plurality of semiconductor chips | 瑞萨电子株式会社 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022023934-A1 | METHOD OF OPERATING A SURGICAL INSTRUMENT | CILAG GMBH INTERNATIONAL (CH) | 2022-02-03 | — | — | WO | disclosed |
| US-20220031345-A1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | CILAG GMBH INTERNATIONAL (CH) | 2022-02-03 | — | — | US | disclosed |
| US-20220031315-A1 | METHOD OF OPERATING A SURGICAL INSTRUMENT | CILAG GMBH INTERNATIONAL (CH) | 2022-02-03 | — | — | US | disclosed |
| WO-2022023949-A1 | SURGICAL INSTRUMENTS WITH DOUBLE SPHERICAL ARTICULATION JOINTS WITH PIVOTABLE LINKS | CILAG GMBH INTERNATIONAL (CH) | 2022-02-03 | — | — | WO | disclosed |
| US-6515129-B1 | A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis | ISHIHARA SANGYO KAISHA LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-6429212-B1 | AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR | ISHIHARA SANGYO KAISHA LTD. (JP) | 2002-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333460-A1 | MUTANT FGF-21 PEPTIDE PEGYLATED CONJUGATES AND USES THEREOF | FGF1, FGF2, FGF23 | ALDH1A1 793/4885HPGD 2294/4885CYP2D6 3283/4885 |
| US-12639042-B2 | Integrated circuits for large-scale transistor tensor operations | TMCO1, KCNN4, CACNA1C | ALDH1A1 2273/4885HPGD 4809/4885CYP2D6 4012/4885 |
| US-12611211-B2 | Method of operating a surgical instrument | PARL, ALPL, PLAT | ALDH1A1 4309/4885HPGD 4142/4885CYP2D6 4502/4885 |
| US-20260072645-A1 | INTEGRATED CIRCUITS FOR LARGE-SCALE TRANSISTOR TENSOR OPERATIONS | TMCO1, KCNN4, CACNA1C | ALDH1A1 2273/4885HPGD 4809/4885CYP2D6 4012/4885 |
| US-20260073966-A1 | INTEGRATED CIRCUITS FOR LARGE-SCALE TRANSISTOR TENSOR OPERATIONS | TMCO1, CACNA1C, KCNN4 | ALDH1A1 2332/4885HPGD 4863/4885CYP2D6 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.